Hemosil High Abnormal Control Assayed
Plasma, Coagulation Control. 510(k) K021024, from Instrumentation Laboratory CO (Bedford, MA). Product code GGN, class 2.
As of Nov 20, 2026, K021024 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on May 16, 2002 after 48 days, with 3 recalls tied to it in FDA's recall database.
- Review time: 48 days
- Recalls: 3
- Cited as a predicate by: 3 devices
HemosIL High Abnormal Control ASSAYED is intended for the quality control of coagulation assays in the high abnormal range on IL Coagulation and ELECTRAâ„¢ Systems. The High Abnormal Control is prepared using human citrated plasma from healthy donors (not heparinized plasma or plasma samples under oral anticoagulant therapy) and modified to simulate an abnormal coagulation sample.
- Assess(Tm) High Abnormal ControlK931118 · Instrumentation Laboratory CO · Mar 30, 1994
- Il Test 84673-30 Chromogenics Control PlasmaK864271 · Instrumentation Laboratory CO · Nov 25, 1986
- Il Test Proclot Assay StystemK912711 · Instrumentation Laboratory CO · Oct 9, 1991
- CP3000 Coagulation analyzer, Coagpia AT Reagent, Coagpia Calibrator, Coagpia Control SetK173202 · Sekisui Medical Co., Ltd. · May 9, 2018
- Hemosil Routine Control Level 1, Level 2, Level 3 UnassayedK082859 · Instrumentation Laboratory CO · Dec 19, 2008
- Olympus BF Type UC160-OL8K042140 · Olympus Corporation · Aug 18, 2004
| Started | Recall | Status |
|---|---|---|
| Nov 15, 2013 | Z-0516-2014, Z-0514-2014, Z-0515-2014HemosIL Low, Abnormal, Normal Controls UNASSAYED (no-value assigned) lacks 510(k) approval | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 29, 2002
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5425
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files